GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...
Pfizer shows profit growth from cost cuts and steadier COVID sales
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...
MedPage Today28d
Study Pinpoints Factors Driving COVID Vaccine Hesitancy Among Black Women
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Three main factors contributed to COVID vaccine hesitancy among Black women, according to a qualitative study using ...